Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-14-004813
Filing Date
2014-12-09
Accepted
2014-12-09 16:31:40
Documents
11
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 c79393_10q.htm 10-Q 439098
2 c79393_ex31-1.htm EX-31.1 9377
3 c79393_ex31-2.htm EX-31.2 9369
4 c79393_ex32-1.htm EX-32.1 3417
5 c79393_ex32-2.htm EX-32.2 3431
  Complete submission text file 0000930413-14-004813.txt   4633034

Data Files

Seq Description Document Type Size
6 enz-20141031.xml EX-101.INS 673683
7 enz-20141031.xsd EX-101.SCH 51714
8 enz-20141031_cal.xml EX-101.CAL 41590
9 enz-20141031_def.xml EX-101.DEF 213613
10 enz-20141031_lab.xml EX-101.LAB 308936
11 enz-20141031_pre.xml EX-101.PRE 222294
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 141275410
SIC: 8071 Services-Medical Laboratories